Arcturus Therapeutics Holdings (ARCT) EPS (Basic) (2018 - 2026)
Arcturus Therapeutics Holdings (ARCT) posted EPS (Basic) of -$1.99 for Q1 2026, down 87.69% on a QoQ basis from -$1.06 in Q4 2025, and down 283.6% year-over-year from $1.08 in Q1 2025.
Arcturus Therapeutics Holdings (ARCT) EPS (Basic) (2018 - 2026) Analysis & Trends
Arcturus Therapeutics Holdings' EPS (Basic) history runs 9 years deep, the most recent figure standing at -$1.99 for Q1 2026.
- Quarterly EPS (Basic) fell 283.6% year-over-year to -$1.99 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.81 (down 51.58% YoY) and the FY2025 annual result came in at -$2.4, up 19.89% from the prior year.
- EPS (Basic) was -$1.99 for Q1 2026 at Arcturus Therapeutics Holdings, down from -$1.06 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1911.3 in Q1 2023 and bottomed at -$1979.2 in Q2 2023.
- A 5-year average of -$40.36 and a median of -$0.82 in 2022 frame the typical range for EPS (Basic).
- Peak annual rise in EPS (Basic) reached 98428.19% in 2023, while the deepest fall reached 242444.51% in 2023.
- Arcturus Therapeutics Holdings' EPS (Basic) stood at $4.49 in 2022, then tumbled by 109.8% to -$0.44 in 2023, then tumbled by 152.77% to -$1.11 in 2024, then gained by 4.5% to -$1.06 in 2025, then plunged by 87.69% to -$1.99 in 2026.
- Business Quant data shows ARCT's EPS (Basic) at -$1.99 in Q1 2026, -$1.06 in Q4 2025, and -$0.49 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Arcturus Therapeutics Holdings | 164.57 Mn | -46.81 Mn | - | -1.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.99 |
| Dec 31, 2025 | -1.06 |
| Sep 30, 2025 | -0.49 |
| Jun 30, 2025 | -0.34 |
| Mar 31, 2025 | -0.52 |
| Dec 31, 2024 | -1.11 |
| Sep 30, 2024 | -0.26 |
| Jun 30, 2024 | -0.64 |
| Mar 31, 2024 | -1.00 |
| Dec 31, 2023 | -0.44 |
| Sep 30, 2023 | -610.71 |
| Jun 30, 2023 | -1,979.18 |
| Mar 31, 2023 | 1,911.28 |
| Dec 31, 2022 | 4.49 |
| Sep 30, 2022 | -1.33 |
| Jun 30, 2022 | -0.82 |
| Mar 31, 2022 | -1.94 |
| Dec 31, 2021 | -1.44 |
| Sep 30, 2021 | -2.33 |
| Jun 30, 2021 | -2.34 |